Epstein-Barr virus in pleural effusions: protagonist or pretender?

Eur Respir J. 2019 Oct 31;54(4):1900825. doi: 10.1183/13993003.00825-2019. Print 2019 Oct.

Authors

David T Arnold¹, Tim Suri², Fergus Hamilton³, Anna Morley⁴, Andrew Medford⁴, Ian B Vipond⁵, Peter Muir⁵, Nick A Maskell⁴

Affiliations

¹ Academic Respiratory Unit, School of Translational Health Sciences, University of Bristol, Bristol, UK arnold.dta@gmail.com.
² School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
³ Dept of Microbiology, North Bristol NHS Trust, Bristol, UK.
⁴ Academic Respiratory Unit, School of Translational Health Sciences, University of Bristol, Bristol, UK.
⁵ Public Health England, South West Regional Laboratory, National Infection Service, Bristol, UK.

PMID: 31248955
DOI: 10.1183/13993003.00825-2019

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Aged
Aged, 80 and over
Case-Control Studies
DNA, Viral / analysis*
Epstein-Barr Virus Infections / complications
Epstein-Barr Virus Infections / diagnosis*
Female
Herpesvirus 4, Human / genetics
Humans
Male
Middle Aged
Pleura / pathology*
Pleural Effusion / etiology
Pleural Effusion / pathology
Pleural Effusion / virology*
Pleurisy / complications
Pleurisy / pathology
Pleurisy / virology*
Prospective Studies
Real-Time Polymerase Chain Reaction

Substances

DNA, Viral

Grants and funding

DRF-2018-11-ST2-065/DH_/Department of Health/United Kingdom